MindMed's Q2 2023: One Of Biggest Players In The Space Sustains Faith In LSD's Multiple Path Ahead - Mind Medicine (NASDAQ:MNMD)
Clinical-stage psychedelics biotech MindMed’s (NASDAQ: MNMD) unaudited financial results for the quarter ended June 30, 2023 look like this:
Robert Barrow University Hospital Basel Generalized Anxiety Disorder Autism Spectrum Disorder Mindmed Phase
Source: benzinga.com